Stay updated on Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.

Latest updates to the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page
- Check2 days agoChange DetectedClinicalTrials.gov has updated its page revision/version number from v3.5.2 to v3.5.3, indicating a platform or display update rather than a change to the underlying study record.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed, indicating an internal site version update. No substantive study content or functionality changes are evident on the page.SummaryDifference0.1%

- Check45 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and Revision: v3.4.1.SummaryDifference0.5%

- Check81 days agoChange DetectedThe page displays a government funding lapse notice and a site status message. The release note updates from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin and Beta-cell Preservation in GDM Women Clinical Trial page.